Allogeneic stem cell transplantation in AML with t(6;9)(p23;q34); DEK‐NUP214 shows a favourable outcome when performed in first complete remission

Author:

Díaz‐Beyá Marina12ORCID,Labopin Myriam3ORCID,Maertens Johan4ORCID,Alijurf Mahmoud5,Passweg Jakob6,Dietrich Beelen7ORCID,Schouten Harry8ORCID,Socié Gerard9ORCID,Schaap Nicolaas10ORCID,Schwerdtfeger Rainer11,Volin Liisa12ORCID,Michallet Mauricette13ORCID,Polge Emmanuelle3ORCID,Sierra Jorge14ORCID,Mohty Mohamad315ORCID,Esteve Jordi1216ORCID,Nagler Arnon317ORCID,

Affiliation:

1. Hematology Department Hospital Clínic of Barcelona BarcelonaSpain

2. IDIBAPS Josep Carreras Leukemia Research Institute Barcelona Spain

3. EBMT Paris Study Office Department of Hematology and Cell Therapy Hôpital Saint‐Antoine Paris France

4. University Hospital Gasthuisberg Leuven Belgium

5. King Faisal Specialist Hospital & Research Centre Oncology Riyadh Saudi Arabia

6. University Hospital Hematology Basel Switzerland

7. Department of Bone Marrow Transplantation University Hospital EssenGermany

8. Department of Internal Medicine, Hematology/Oncology University Hospital Maastricht The Netherlands

9. Division of Hematology Hospital Saint Louis & University Paris Paris France

10. Radbud University Medical Centre Nijmegen The Netherlands

11. Center for Hematopoietic Cell Transplantation Deutsche Klinik für Diagnostik Helios Klinik Wiesbaden Germany

12. Stem Cell Transplantation Unit Comprehensive Cancer Center Helsinki University Hospital Helsinki Finland

13. Hôpital Edouard Herriot Lyon France

14. Hematology Department Hospital de la Santa Creu i Sant PauIIB‐Santpau and Josep Carreras Leukemia Research InstituteAutonomous University of Barcelona Barcelona Spain

15. Department of Hematology Hospital Saint Antoine Paris France

16. Medicine Department University of Barcelona Barcelona Spain

17. Hematology Division Chaim Sheba Medical Center Tel‐Hashomer Israel

Funder

Generalitat de Catalunya

Publisher

Wiley

Subject

Hematology

Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3